Decreased expression of heparanase in glioblastoma multiforme
Authors:
- Masaaki YamamotoMYMasaaki Yamamoto
- Israel VlodavskyIVIsrael Vlodavsky
- Iris PeckerIPIris Pecker
- Kohichi OhshimaKOKohichi Ohshima
- Takeo FukushimaTFTakeo Fukushima
- 1 March 2005
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 102 (3) , 513-521
Abstract
Object. The authors investigated the presence of endoglycosidase heparanase in human glioblastoma multiforme (GBM) and metastatic brain tumors as well as in healthy brain tissue to explore the relationship between the biological characteristics of GBM and the role of heparanase. Methods. Heparanase messenger (m)RNA was almost undetectable in GBMs in vivo, whereas it was frequently seen in metastatic brain tumors according to results of reverse transcription—polymerase chain reaction (RT-PCR). Immunohistochemical analysis of paraffin-embedded tissue sections showed that neoplastic cells in metastatic brain tumors, especially in cells that invaded blood vessels, exhibit intense heparanase immunoreactivity. Heparanase was present in two highly invasive glioma cell lines, U87MG and U251MG, in vitro. These cell lines did not have metastatic capability, which was tested in an experimental pulmonary metastases model in mice. The activity of heparanase in these cell lines was almost the same as that in the highly metastatic melanoma cell line B16-F1. After nude mice were inoculated with U87MG cells, however, heparanase was no longer detected in subcutaneous or intracerebral experimental glioma in vivo based on results of immunohistochemical analysis. According to results of real-time quantitative PCR, there was a 10-fold increase in heparanase mRNA in U87MG glioma cells in vitro compared with that in experimental U87MG glioma tissue in vivo in nude mice. Conclusions. These results indicate that the expression of heparanase was downregulated in GBM in vivo, which rarely metastasizes to distant organs outside the central nervous system. Heparanase is not implicated in the invasiveness of GBM to surrounding healthy brain tissue in vivo.Keywords
This publication has 34 references indexed in Scilit:
- Heparanase: A Key Enzyme in Invasion and Metastasis of Gastric CarcinomaLaboratory Investigation, 2002
- Expression of Heparanase in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa and StromaThe American Journal of Pathology, 2000
- RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteasesOncogene, 1999
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999
- Real time quantitative PCR.Genome Research, 1996
- Glioma Invasion in the Central Nervous SystemNeurosurgery, 1996
- Lysolecithin-induced Alteration of Subendothelial Heparan Sulfate Proteoglycans Increases Monocyte Binding to MatrixJournal of Biological Chemistry, 1995
- Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasivenessBioEssays, 1993
- Heparanases and tumor metastasisJournal of Cellular Biochemistry, 1988
- The pathogenesis of cancer metastasisNature, 1980